US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 144.080
  • +1.590+1.12%
Close Feb 14 16:00 ET
  • 144.080
  • 0.0000.00%
Post 17:04 ET
8.62BMarket Cap-21.08P/E (TTM)

About Ascendis Pharma A/S Company

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Company Profile

SymbolASND
Company NameAscendis Pharma A/S
Listing DateJan 28, 2015
Issue Price18.00
Founded2006
CEOMr. Jan Moller Mikkelsen
MarketNASDAQ
Employees1017
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressTuborg Boulevard 12
CityHellerup
ProvinceCapital Region
CountryDenmark
Zip Code2900
Phone45-70-22-22-44
Websitehttp://www.ascendispharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Jan Moller Mikkelsen
  • President, Chief Executive Officer and Director
  • --
  • Scott T Smith
  • Executive Vice President and Chief Financial Officer
  • --
  • Aimee Shu
  • Executive Vice President and Chief Medical Officer
  • --
  • Lotte Sonderbjerg
  • Executive Vice President and Chief Administrative Officer
  • --
  • Michael Wolff Jensen
  • Executive Vice President and Chief Legal Officer
  • --
  • Mads Bodenhoff
  • Senior Vice President, Head of Finance and Principal Accounting Officer
  • --
  • Dr. Stina Singel, M.D.
  • Executive Vice President and Head of Clinical Development, Oncology
  • --
  • Dr. Kennett Sprogoe, PhD
  • Executive Vice President and Head of Innovation and Research
  • --
  • Flemming Steen Jensen
  • Executive Vice President, Product Supply and Quality
  • --
  • Jay Donovan Wu
  • Executive Vice President and U.S. President
  • --
  • Dr. Albert Cha, M.D.,PhD
  • Chairman of the Board
  • --
  • William Carl Fairey
  • Independent Director
  • --
  • Lisa Bright
  • Independent Director
  • --
  • Lars Holtug
  • Independent Director
  • --
  • Siham Imani
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!